Citadel Advisors
ACB

Citadel Advisors’s Aurora Cannabis ACB Stock Holding History

Citadel Advisors’s Portfolio ACB Stock Details ACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$524K Buy
187,700
+55,100
+42% +$184K ﹤0.01% 9752
2026
Q1 		$434K Sell
132,600
-558,370
-81% -$2.11M ﹤0.01% 9645
2025
Q4 		$2.92M Buy
690,970
+328,370
+91% +$1.61M ﹤0.01% 5220
2025
Q3 		$2.16M Buy
362,600
+142,620
+65% +$696K ﹤0.01% 5921
2025
Q2 		$933K Sell
219,980
-100,900
-31% -$489K ﹤0.01% 7257
2025
Q1 		$1.41M Buy
320,880
+149,380
+87% +$706K ﹤0.01% 6212
2024
Q4 		$729K Buy
171,500
+15,200
+10% +$74.6K ﹤0.01% 7724
2024
Q3 		$919K Sell
156,300
-43,170
-22% -$256K ﹤0.01% 7042
2024
Q2 		$922K Sell
199,470
-42,880
-18% -$272K ﹤0.01% 6755
2024
Q1 		$1.06M Buy
242,350
+196,250
+426% +$760K ﹤0.01% 6789
2023
Q4 		$220K Buy
46,100
+9,520
+26% +$45.9K ﹤0.01% 9760
2023
Q3 		$214K Buy
36,580
+19,220
+111% +$112K ﹤0.01% 9771
2023
Q2 		$92.8K Sell
17,360
-14,040
-45% -$82.8K ﹤0.01% 11048
2023
Q1 		$219K Sell
31,400
-9,380
-23% -$82.1K ﹤0.01% 10017
2022
Q4 		$376K Sell
40,780
-10,090
-20% -$120K ﹤0.01% 8844
2022
Q3 		$621K Sell
50,870
-12,910
-20% -$190K ﹤0.01% 7988
2022
Q2 		$842K Buy
63,780
+3,030
+5% +$75.9K ﹤0.01% 7432
2022
Q1 		$2.43M Buy
60,750
+3,540
+6% +$150K ﹤0.01% 5664
2021
Q4 		$3.1M Sell
57,210
-43,598
-43% -$2.93M ﹤0.01% 5277
2021
Q3 		$6.98M Sell
100,808
-145,872
-59% -$10.4M ﹤0.01% 3685
2021
Q2 		$22.3M Buy
246,680
+173,880
+239% +$15.1M 0.01% 1947
2021
Q1 		$6.78M Buy
72,800
+19,790
+37% +$2.21M ﹤0.01% 3655
2020
Q4 		$4.41M Buy
53,010
+29,470
+125% +$2.15M ﹤0.01% 3891
2020
Q3 		$1.09M Sell
23,540
-1,480
-6% -$141K ﹤0.01% 5876
2020
Q2 		$3.11M Buy
25,020
+3,470
+16% +$395K ﹤0.01% 3804
2020
Q1 		$2.34M Buy
21,550
+848
+4% +$151K ﹤0.01% 3896
2019
Q4 		$5.37M Buy
20,702
+11,065
+115% +$4.13M ﹤0.01% 2991
2019
Q3 		$5.08M Buy
9,637
+4,175
+76% +$3.09M ﹤0.01% 3095
2019
Q2 		$5.13M Sell
5,462
-3,622
-40% -$3.64M ﹤0.01% 3043
2019
Q1 		$9.88M Buy
9,084
+7,996
+735% +$7.15M ﹤0.01% 2094
2018
Q4 		$648K Buy
+1,088
New +$802K ﹤0.01% 5994

Other funds holding ACB

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $57.8B AUM 72.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Citadel Advisors's ACB Position: Q2 2026 in Review

Citadel Advisors sold out of Aurora Cannabis (ACB) in Q2 2026, closing a stake of 252,312 shares — an estimated $844K sold.

Citadel Advisors first reported a position in ACB in Q4 2018 and held it in 27 quarters. The position peaked at $14.9M in Q1 2021. 149 funds tracked by Wall St. Rank hold ACB as of Q2 2026.

  • Citadel Advisors reported no remaining Aurora Cannabis position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 252,312 Aurora Cannabis shares in Q2 2026, an estimated $844K.
  • Citadel Advisors first reported a position in Aurora Cannabis in Q4 2018 and held it in 27 quarters.
  • Citadel Advisors's Aurora Cannabis position peaked at $14.9M in Q1 2021.
  • 149 funds tracked by Wall St. Rank held Aurora Cannabis as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.